Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Candesartan cilexetil

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Candesartan cilexetil Manufacturers in India Suppliers Candesartan cilexetil Exporters Distributors Candesartan cilexetil api active pharmaceuticals ingredients Candesartan cilexetil manufacturers Side Effects bulk drugs raw material Candesartan cilexetil companies Side Effects Importers Candesartan cilexetil Candesartan cilexetil Exporters Candesartan cilexetil exporters FDA Candesartan cilexetil DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Candesartan cilexetil manufacturing pharmaceutical drugs pharmaceutical intermediates Candesartan cilexetil pharmaceutical chemicals pharmaceutical raw materials Candesartan cilexetil active pharmaceutical ingredients Candesartan cilexetil committee active pharmaceutical ingredients manufacturer Candesartan cilexetil Active Pharmaceutical Ingredients manufacturer Candesartan cilexetil exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Candesartan cilexetil, Candesartan cilexetil manufacturer India, Candesartan cilexetil product, Candesartan cilexetil products, Api preparation, Certificate of Analysis API manufacturer product, Candesartan cilexetil anti ulcer product, Certificate of Origin COA Candesartan cilexetil COS Candesartan cilexetil, pharmaceutical generic, pharmaceutical drug, medical, Candesartan cilexetil pharma healthcare, pharma patents, contract MSDS manufacturing Trader Candesartan cilexetil pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Candesartan cilexetil expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Candesartan cilexetil DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Candesartan cilexetil ingredients, api, HIV Candesartan cilexetil, tablets, capsules, syrup & protein Candesartan cilexetil powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Candesartan cilexetil gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Candesartan cilexetil WHO, UKMHRA Approval

 
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
   
active drug,

hypertension drug












 

 

 










 

 

 

 
HOME >> Pharmaceuticals API List 1 >> Candesartan Cilexetil

Candesartan cilexetil   CAS No. : 145040-37-5
Candesartan cilexetil
pdf api
145040-37-5

Chemical Formulas
 
Candesartan cilexetil   Molecular formula: C33H34N6O6

Description

1. CAS No. : 145040-37-5
2. Molecular formula: C33H34N6O6
3. Molecular weight: 610.67
4. Appearance:White crystalline powder
5. Assay≥99.0%
6. Total impurity:≤1.0%
7. Single impurity≤0.5%
8. Residule on ignition≤0.1 
9. Heavy metal≤10PPm 


Candesartan cilexetil is a white to off-white powder with a molecular weight of 610.67. It is practically insoluble in water and sparingly soluble in methanol. Candesartan cilexetil is a racemic mixture containing one chiral center at the cyclohexyloxycarbonyloxy ethyl ester group. Following oral administration, candesartan cilexetil undergoes hydrolysis at the ester link to form the active drug, candesartan, which is achiral.
 

Candesartan cilexetil is the generic name for this medicine. It is available as the following brands. Please select one of the medicines below for information about Candesartan cilexetil:


Candesartan cilexetil, a nonpeptide, is chemically described as ()-1-Hydroxyethyl 2-ethoxy-1-[p-(o- 1H-tetrazol-5-ylphenyl)benzyl]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester).

Many research efforts are focused on finding ways to lower urinary protein excretion in patients with kidney disease because doing so may postpone kidney failure and prevent the development of cardiovascular disease. Investigators in Canada recently reported the results of a multicenter trial that evaluated whether high doses of the hypertension drug candesartan cilexetil could reduce proteinuria better than the maximum approved dose.


Information Associated with Product :  

Dosage
Uses
Side Effects
Pharmacology

                       
PDF DOWNLOAD      WORD DOCUMENT

Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo
 

Candesartan Cilaxetil

More Api at Taj Pharmaceuticals Ltd.

Alfuzosin

Oseltamivir Phosphate

 Amlodipine Besylate

Aripiprazole

Atorvastatin Calcium

Candesartan Cilaxetil

Cefdinir

Cetirizine Dihydrochloride

Ciprofloxacin HCl

Dextromethorphan Base

Diltiazem HCl

Domperidone Base

Domperidone Maleate

Doxazosin Mesylate

 Duloxetine HCl

Dutasteride

Enalapril Maleate

Esomeprazole Magnesium

Famotidine

Fexofenadine HCl

Fluconazole

Fluoxetine HCl

Galantamine HBr

Ibuprofen

Caffeine

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

    Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.